NYSEMaterialsChemicalsSnapshot 2026-07-23
Reading HUN? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround story with a focus on improving profitability and cash flow. The current thesis state is cautious, as the company is loss-making and operates in a high-risk environment.
The market seems to have priced in a low expectations gap, indicating that HUN is viewed as cheap compared to its peers. However, the valuation reflects concerns about its recent financial performance and the headwinds in the materials sector.
Management is focused on increasing profitability through pricing initiatives and enhancing cash flow from operations. Recent financial results show slight improvements, but the company remains in a loss-making position.
The long-term thesis hinges on management's ability to execute on profitability and cash flow goals. Additionally, external factors such as inflation trends and the performance of sector peers will significantly impact HUN's trajectory.
Over the next 1 to 3 years, HUN's performance will depend on its execution of management priorities and broader market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
risk label changed from 'elevated' to 'high'.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: A positive change in sector revenue growth could signal a recovery for Huntsman Corp.
Confirms:Sector revenue growth turns positive after being near -1 percent for three years.
Disproves:Sector revenue growth remains negative or worsens.
Why it matters: The merger will create a $12.5 billion chemicals leader. It could unlock over $400 million in cost synergies.
Confirms:The merger closes on time in the first half of 2027 with all regulatory approvals secured.
Disproves:The merger may be delayed or may not get the needed approvals.
Why it matters: This report will show if the company can improve its weak momentum and financials.
Confirms one read:Q2 earnings report shows revenue growth turning positive year over year.
Confirms the other:Q2 earnings report shows revenue continuing to decline year over year.
Why it matters: Staying within this range is crucial for managing cash flow and funding operations. It shows financial discipline.
Confirms:Management says capital spending is between $170M and $180M.
Disproves:Capital spending is over $180M. This shows poor financial management.
Why it matters: Better profits would show that pricing strategies are working. This is important for Huntsman's growth.
Confirms:Management says profit margins have increased a lot due to pricing changes.
Disproves:Profit margins remain flat or decline despite pricing efforts.
Why it matters: Management thinks profits will rise because of price changes and more sales.
Confirms:Q2 2026 earnings report shows adjusted EBITDA much higher than $73 million.
Disproves:The Q2 2026 earnings report shows adjusted EBITDA is less than $73 million.
Why it matters: Improving cash flow is critical for financial health and supports the merger's success.
Confirms:Free cash flow improves to a use of cash less than $90 million in Q2 2026.
Disproves:Free cash flow remains worse than a use of cash of $90 million in Q2 2026.
